Lamivir HBV Tablet
Marketer
Cipla Ltd
Salt Composition
Lamivudine (100mg)
Overview Lamivir HBV Tablet
HepBGuard tablets are indicated for managing HIV infection and chronic hepatitis B (HBV). The medication works by inhibiting viral replication within human cells, thereby reducing the viral load and slowing disease progression. HepBGuard is not a cure for HIV/AIDS; it reduces the amount of HIV, minimizing the risk of complications and potentially extending lifespan. It's always prescribed alongside other antiretroviral agents. Your physician will determine the optimal medication regimen and dosage. Adhere strictly to the prescribed instructions for all medications. HepBGuard may be taken with or without food. Consistent, timely medication adherence significantly enhances efficacy and diminishes the likelihood of HIV developing resistance. Missed doses should be avoided, and treatment should continue until medically advised to stop. Common side effects include headache, nausea, vomiting, abdominal discomfort, tiredness, diarrhea, and skin rash. While usually mild, persistent or bothersome symptoms warrant medical attention. Rarely, skin reactions or liver injury can occur; close monitoring, especially initially, is essential. Inform your doctor about pre-existing skin conditions, liver or kidney issues before commencing treatment. Regular blood tests to monitor blood cell counts and liver function are often required. Alcohol consumption should be avoided due to the increased risk of liver damage. Pregnant or lactating individuals should seek medical counsel prior to use. If HIV positive, avoid unprotected sex and sharing personal items such as razors or toothbrushes. Discuss safe sex practices, including condom use, with your doctor to prevent HIV transmission.
Uses of Lamivir HBV Tablet
Persistent infection with the hepatitis B virus (HBV)
Major Benefits of Lamivir HBV Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Lamivir HBV Tablet can be administered with or without food, but consistent timing is recommended.
Common Side effects of Lamivir HBV Tablet:
- Headache
- Nausea
- Diarrhea
- Vomiting
- Fatigue
- Stomach pain
- Rash
How to use Lamivir HBV Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not crush, chew, or divide it. Lamivir HBV Tablets can be administered with or without food, however, consistent timing is recommended.
How Lamivir HBV Tablet works:
Hepatitis B virus replication is inhibited by the antiviral Lamivir HBV Tablet. This action prevents further viral production within human cells, leading to infection resolution.
SAFETY ADVICE
AlcoholCAUTION
Use of Lamivir HBV Tablet with alcohol requires medical supervision. Consult your physician before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Lamivir HBV Tablet during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against potential dangers prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Lamivir HBV tablets without significant risk to their infants. Available human data indicates minimal danger to the baby.
DrivingSAFE
Driving ability is typically unaffected by Lamivir HBV Tablet.
KidneyCAUTION
Patients with kidney impairment should use Lamivir HBV Tablets cautiously, as dose modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Hepatic impairment does not necessitate altered dosing of Lamivir HBV tablets, which are considered safe for patients with liver disease.
What if you forget to take Lamivir HBV Tablet :
Should you forget a Lamivir HBV Tablet dose, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Lamivir HBV Tablet
| Label | Value |
|---|---|
| Chemical Category | Base analog nucleotide |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Action Class | Reverse transcriptase inhibitors (RTIs) based on nucleosides or nucleotides |






